Document Detail


Statin therapy and contrast-induced nephropathy after primary angioplasty.
MedLine Citation:
PMID:  18466989     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A recent study suggested that statin therapy may prevent contrast-induced nephropathy (CIN) following primary angioplasty. Our aim was to assess the effect of statins in this setting in a larger population. We evaluated 589 consecutive patients with acute myocardial infarction who underwent primary angioplasty at our institution. Contrast-induced nephropathy was defined as an increase in serum creatinine by > or =0.5 mg/dL within 72 h following the procedure. Overall, 69 patients (11.9%) developed CIN. The incidence of CIN in the group on statins was 15.9%, as compared with 10.8% in the group not taking statins (p=0.2). Thus, we did not observe a protective effect of statin therapy on CIN development after primary angioplasty.
Authors:
Alberto Bouzas-Mosquera; Jos? M V?zquez-Rodr?guez; Ram?n Calvi?o-Santos; Nicol?s V?zquez-Gonz?lez; Alfonso Castro-Beiras
Related Documents :
8280789 - Increased oxidizability of plasma low density lipoprotein from patients with coronary a...
15172899 - Association of statin therapy with outcomes of acute coronary syndromes: the grace study.
686939 - Cholesterol embolization: a complication of angiography.
3265059 - Aortic intimal lipid content and serum lipoproteins in patients undergoing coronary by-...
20110529 - Noncalcified coronary plaque in systemic lupus erythematosus.
7137149 - Contrasting patterns of familiality for cholesterol and triglyceride in finland accordi...
9363739 - Priming of neutrophils after elective percutaneous transluminal coronary angioplasty is...
16325819 - Efficacy of peroxisome proliferative activated receptor (ppar)-alpha ligands, fenofibra...
679439 - The effect of free fatty acids on myocardial oxygen consumption during atrial pacing an...
Publication Detail:
Type:  Comment; Letter     Date:  2008-05-07
Journal Detail:
Title:  International journal of cardiology     Volume:  134     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-05-11     Completed Date:  2010-02-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  430-1     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary* / adverse effects
Contrast Media / adverse effects*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Kidney Failure, Acute / chemically induced*,  drug therapy*,  prevention & control
Risk Factors
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors
Comments/Corrections
Comment On:
Int J Cardiol. 2008 Jun 6;126(3):435-6   [PMID:  17462753 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary hypertension in an adult sickle cell population in Guadeloupe.
Next Document:  Quantifying fungal infection of plant leaves by digital image analysis using Scion Image software.